Cited by 259Chemokine receptors and signalingAngiogenesis and VEGF in CancerConnective Tissue Growth Factor Research

Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.

Open access
Arenberg, D A, Keane, M P, DiGiovine, B, Kunkel, S L, Morris, S B, Xue, Y Y, Burdick, M D, Glass, M C +2 more·1998·Journal of Clinical Investigation

Abstract

We report here the role of the CXC chemokine, epithelial neutrophil activating peptide (ENA-78), as an angiogenic factor in human non-small cell lung cancer (NSCLC). In freshly isolated human specimens of NSCLC, elevated levels of ENA-78 were found that strongly correlated with the vascularity of the tumors. In a SCID mouse model of human NSCLC tumorigenesis, expression of ENA-78 in developing tumors correlated with tumor growth in two different NSCLC cell lines. Furthermore, passive immunization of NSCLC tumor-bearing mice with neutralizing anti-ENA-78 antibodies reduced tumor growth, tumor vascularity, and spontaneous metastases, while having no effect on the proliferation of NSCLC cells either in vitro or in vivo. These findings suggest that ENA-78 is an important angiogenic factor in human NSCLC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci3145

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In mouse models, ENA-78/CXCL5 variably affects tumour growth, vascularity and apoptosis.

    “in mouse models, ENA-78/CXCL5 variably affects tumour growth, vascularity and apoptosis46.”

    From Inflammation and cancer (2002) · cites this paper as [46]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Arenberg, D. A., Keane, M. P., DiGiovine, B., Kunkel, S. L., Morris, S. B., Xue, Y. Y., Burdick, M. D., Glass, M. C., Iannettoni, M. D., & Strieter, R. M.
Affiliations
University of Michigan (US)
Venue
Journal of Clinical Investigation
Published
1998-08-01
Volume
102
Issue
3
Pages
465-472
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2051810280
Cited by
259
References
32
Citations by year
2025: 4 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 11 · 2020: 8 · 2019: 4 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 14 · 2014: 11 · 2013: 10 · 2012: 9
FWCI
3.21
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Michigan
  • National Institutes of Health (1r01ca066180-01a1, 5k08ca072543-05, 5r01hl050057-05, CA66180, HL35276, CA72543)
  • National Heart, Lung, and Blood Institute (HL50057)
  • National Cancer Institute (CA66180, CA72543)
Topics
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
Keywords
CXCL5, CXC chemokines, angiogenesis, non-small cell lung cancer, tumor vascularity, tumor growth, metastasis, neutralizing antibodies, SCID mouse xenograft
MeSH terms
Adenocarcinoma, Animals, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Cell Division, Female, Humans, Immunization, Passive, Lung Neoplasms, Neoplasm Proteins, Neoplasm Transplantation, Neovascularization, Pathologic, Tumor Cells, Cultured, Interleukin-8, Mice, SCID, Apoptosis, Chemokines, CXC, Mice, Rats, Chemokine CXCL5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review